Review decisions
Showing 410 results of 1553 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1694620401479
Product Type: Drug
Control Number: 253753
DIN(s): 02229056
Manufacturer: Bracco Imaging Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-06-14
Decision / Authorization Date: 2022-01-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1694621051185
Product Type: Drug
Control Number: 219788
Manufacturer: Pendopharm Division of Pharmascience Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2018-09-17
Decision / Authorization Date: 2021-12-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689349413724
Product Type: Drug
Control Number: 266244
DIN(s): 02522551, 02522578, 02522586, 02522594, 02522608, 02528509, 02528517, 02528525, 02528533, 02528541
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-07-20
Decision / Authorization Date: 2023-06-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689946984717
Product Type: Drug
Control Number: 266537
DIN(s): 02470365, 02492504, 02510049, 02524252, 02526190
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-08-03
Decision / Authorization Date: 2023-07-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1693578801415
Product Type: Drug
Control Number: 261689
DIN(s): 02538652, 02538660, 02538725, 02538733, 02538741, 02538814
Manufacturer: Endo Ventures Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-06-09
Decision / Authorization Date: 2023-06-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1693590059350
Product Type: Drug
Control Number: 262870
DIN(s): 02538237
Manufacturer: Jazz Pharmaceuticals Ireland Limited
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-03-29
Decision / Authorization Date: 2023-05-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1688667089344
Product Type: Drug
Control Number: 262080
DIN(s): 02537818
Manufacturer: Avir Pharma Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-04-08
Decision / Authorization Date: 2023-05-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689169951770
Product Type: Drug
Control Number: 265088
DIN(s): 02525755
Manufacturer: Alnylam Netherlands B.v.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-06-09
Decision / Authorization Date: 2023-05-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1687460395389
Product Type: Drug
Control Number: 266464
DIN(s): 02538539
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-07-29
Decision / Authorization Date: 2023-06-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1688659210251
Product Type: Drug
Control Number: 274152
DIN(s): 02531461, 02533197
Manufacturer: Pfizer Canada ULC, on behalf of BioNTech Manufacturing GmbH
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2023-04-06
Decision / Authorization Date: 2023-07-06